Global Drug Metabolism and Pharmacokinetics (DMPK) Market Growth (Status and Outlook) 2024-2030

Global Drug Metabolism and Pharmacokinetics (DMPK) Market Growth (Status and Outlook) 2024-2030

DMPK is an acronym that stands for drug metabolism and pharmacokinetics. This is a discipline that helps to identify drugs that are likely to be suitable for advancement through the drug development process. It considers how the drug is metabolized and processed by the body.

The global Drug Metabolism and Pharmacokinetics (DMPK) market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.

LPI (LP Information)' newest research report, the “Drug Metabolism and Pharmacokinetics (DMPK) Industry Forecast” looks at past sales and reviews total world Drug Metabolism and Pharmacokinetics (DMPK) sales in 2022, providing a comprehensive analysis by region and market sector of projected Drug Metabolism and Pharmacokinetics (DMPK) sales for 2023 through 2029. With Drug Metabolism and Pharmacokinetics (DMPK) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Drug Metabolism and Pharmacokinetics (DMPK) industry.

This Insight Report provides a comprehensive analysis of the global Drug Metabolism and Pharmacokinetics (DMPK) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Drug Metabolism and Pharmacokinetics (DMPK) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Drug Metabolism and Pharmacokinetics (DMPK) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Drug Metabolism and Pharmacokinetics (DMPK) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Drug Metabolism and Pharmacokinetics (DMPK).

United States market for Drug Metabolism and Pharmacokinetics (DMPK) is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Drug Metabolism and Pharmacokinetics (DMPK) is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Drug Metabolism and Pharmacokinetics (DMPK) is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Drug Metabolism and Pharmacokinetics (DMPK) players cover Eurofins Discovery, Inotiv, Evotec, Sai Life Sciences, Sygnature Discovery, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Drug Metabolism and Pharmacokinetics (DMPK) market by product type, application, key players and key regions and countries.

Segmentation by Type:
Small Molecules
Biologics

Segmentation by Application:
Biopharmaceutical Companies
Government and Academic Institutes
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Segmentation by Type:
Small Molecules
Biologics

Segmentation by Application:
Biopharmaceutical Companies
Government and Academic Institutes
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Eurofins Discovery
Inotiv
Evotec
Sai Life Sciences
Sygnature Discovery
WuXi AppTec
Hangzhou Tigermed Consulting Co
Q2 Solutions
Jubilant Biosys
Frontage Laboratories
Invitrocue
Creative Biolabs
CrownBioscience
Agilent
H3D
LABCORP
Bioduro-Sundia
Allucent

Please note: The report will take approximately 2 business days to prepare and deliver.